151 related articles for article (PubMed ID: 20232585)
1. Pimecrolimus for idiopathic guttate hypomelanosis.
Asawanonda P; Sutthipong T; Prejawai N
J Drugs Dermatol; 2010 Mar; 9(3):238-9. PubMed ID: 20232585
[TBL] [Abstract][Full Text] [Related]
2. Topical tacrolimus significantly promotes repigmentation in idiopathic guttate hypomelanosis: a double-blind, randomized, placebo-controlled study.
Rerknimitr P; Disphanurat W; Achariyakul M
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):460-4. PubMed ID: 22324720
[TBL] [Abstract][Full Text] [Related]
3. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba.
Fujita WH; McCormick CL; Parneix-Spake A
Int J Dermatol; 2007 Jul; 46(7):700-5. PubMed ID: 17614797
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic guttate hypomelanosis-like lesions in patients with mycosis fungoides: a new adverse effect of phototherapy.
Friedland R; David M; Feinmesser M; Fenig-Nakar S; Hodak E
J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):1026-30. PubMed ID: 20180893
[TBL] [Abstract][Full Text] [Related]
5. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
Hartmann A; Bröcker EB; Hamm H
J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic guttate hypomelanosis: idiopathic or ultraviolet induced?
Kaya TI; Yazici AC; Tursen U; Ikizoglu G
Photodermatol Photoimmunol Photomed; 2005 Oct; 21(5):270-1. PubMed ID: 16149941
[TBL] [Abstract][Full Text] [Related]
7. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
Hui RL; Lide W; Chan J; Schottinger J; Yoshinaga M; Millares M
Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
[TBL] [Abstract][Full Text] [Related]
8. Pimecrolimus 1% cream for perianal atopic dermatitis.
Kreuter A; Hochdorfer B; Altmeyer P; Gambichler T
Br J Dermatol; 2005 Jan; 152(1):186-7. PubMed ID: 15656832
[No Abstract] [Full Text] [Related]
9. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review.
Scheinfeld N
Dermatol Online J; 2004 Jul; 10(1):3. PubMed ID: 15347485
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years.
Paul C; Cork M; Rossi AB; Papp KA; Barbier N; de Prost Y
Pediatrics; 2006 Jan; 117(1):e118-28. PubMed ID: 16361223
[TBL] [Abstract][Full Text] [Related]
11. Topical pimecrolimus in the treatment of seborrheic dermatitis.
Brownell I; Quan LT; Hsu S
Dermatol Online J; 2003 Aug; 9(3):13. PubMed ID: 12952760
[TBL] [Abstract][Full Text] [Related]
12. Combination of non-ablative fractional photothermolysis and 0.1% tacrolimus ointment is efficacious for treating idiopathic guttate hypomelanosis.
Chitvanich S; Rerknimitr P; Panchaprateep R; Pongprutthipan M; Asawanonda P
J Dermatolog Treat; 2016 Oct; 27(5):456-60. PubMed ID: 26864301
[TBL] [Abstract][Full Text] [Related]
13. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison.
Draelos Z; Nayak A; Pariser D; Shupack JL; Chon K; Abrams B; Paul CF
J Am Acad Dermatol; 2005 Oct; 53(4):602-9. PubMed ID: 16198779
[TBL] [Abstract][Full Text] [Related]
15. Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus.
Lubaki LJ; Ghanem G; Vereecken P; Fouty E; Benammar L; Vadoud-Seyedi J; Dell'Anna ML; Briganti S; Picardo M; Heenen M
Arch Dermatol Res; 2010 Mar; 302(2):131-7. PubMed ID: 19547993
[TBL] [Abstract][Full Text] [Related]
16. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
Chu CY
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
[TBL] [Abstract][Full Text] [Related]
17. Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis.
Papp K; Staab D; Harper J; Potter P; Puig L; Ortonne JP; Molloy S; Barbier N; Paul C;
Int J Dermatol; 2004 Dec; 43(12):978-83. PubMed ID: 15569038
[TBL] [Abstract][Full Text] [Related]
18. Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin.
Pagnoni A; Kligman AM; Sadiq I; Stoudemayer T
Acta Derm Venereol; 1999 Jul; 79(4):305-10. PubMed ID: 10429990
[TBL] [Abstract][Full Text] [Related]
19. Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy.
Cook BA; Warshaw EM
Am J Clin Dermatol; 2009; 10(2):103-18. PubMed ID: 19222250
[TBL] [Abstract][Full Text] [Related]
20. An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance.
Langley RG; Luger TA; Cork MJ; Schneider D; Paul C
Dermatology; 2007; 215 Suppl 1():27-44. PubMed ID: 18174691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
